Visual Evoked Potentials as a Biomarker in Multiple Sclerosis and Associated Optic Neuritis

@article{Leocani2018VisualEP,
  title={Visual Evoked Potentials as a Biomarker in Multiple Sclerosis and Associated Optic Neuritis},
  author={L. Leocani and S. Guerrieri and G. Comi},
  journal={Journal of Neuro-Ophthalmology},
  year={2018},
  volume={38},
  pages={350–357}
}
&NA; From the Section Editor: The next two installments in the JNO “Disease of the Year: Multiple Sclerosis” series focus on lessons that can be learned form the afferent visual pathway, as a putative model of MS. In their article entitled, “Visual evoked potentials as a biomarker in multiple sclerosis and associated optic neuritis” Leocani and colleagues highlight the role of visual evoked potential (VEP) testing as a means of capturing the effects of demyelination, remyelination, and… Expand
Optic nerve region in multiple sclerosis diagnosis: the utility of visual evoked potentials.
TLDR
The addition of the optic nerve, assessed by VEP, as a fifth region in the current DIS criteria slightly improve the diagnostic performance as it increases sensitivity without losing specificity. Expand
The Comparison of VEP Parameters in Neuromyelitis Optica Spectrum Disorders and Multiple Sclerosis Patients with Acute Optic Neuritis
Date of accept: 04 June 2020 ABSTRACT Introduction: Multiple sclerosis (MS) and neuromyelitis optica spectrum disorders (NMOSD) are idiopathic, autoimmune, and central nervous system inflammatoryExpand
Optic Nerve Topography in Multiple Sclerosis Diagnosis
Objective To assess the added value of the optic nerve region (by using visual evoked potentials [VEPs]) to the current diagnostic criteria. Methods From the Barcelona clinically isolated syndromeExpand
Optical Coherence Tomography and Visual Evoked Potentials as Prognostic and Monitoring Tools in Progressive Multiple Sclerosis
Understanding the mechanisms underlying progression and developing new treatments for progressive multiple sclerosis (PMS) are among the major challenges in the field of central nervous system (CNS)Expand
Atypical optic neuritis: An overview.
Optic neuritis (ON) refers to conditions that involve inflammation of the optic nerve. Various autoantibodies have been found, which are associated with central nervous system inflammatory disordersExpand
Evoked potentials as a translatable biomarker to track functional remyelination
TLDR
The methods developed here allow for longitudinally tracking functional myelination changes in vivo in preclinical rodent models with a quantitative biomarker that can also be applied clinically and will facilitate translational development of CNS remyelinating therapies. Expand
Citicoline: A Candidate for Adjunct Treatment of Multiple Sclerosis
TLDR
Citicoline, known for many years as a nootropic and neuroprotective drug and recently pronounced food supplement, has been found to be significantly efficacious in two complementary rodent models of MS, experimental autoimmune encephalomyelitis (EAE) and cuprizone-induced myelin toxicity. Expand
Prognostic Factors for Recovery of Vision in Canine Optic Neuritis of Unknown Etiology: 26 Dogs (2003–2018)
TLDR
Prognostic factors that may influence complete recovery of vision in dogs with ON are identified and a larger cohort of dogs is required to determine whether these findings are robust and whether additional parameters aid accurate prognosis for recovery of sight in canine ON. Expand
Machine Learning Analysis of Motor Evoked Potential Time Series to Predict Disability Progression in Multiple Sclerosis
TLDR
A machine learning analysis of motor EP that uses the whole time series, instead of a few variables, to predict disability progression after two years, shows promising predictive performance. Expand
Machine learning analysis of motor evoked potential time series to predict disability progression in multiple sclerosis
TLDR
A machine learning analysis of motor EP that uses the whole time series, instead of a few variables, to predict disability progression after two years, shows promising predictive performance. Expand
...
1
2
...

References

SHOWING 1-10 OF 119 REFERENCES
The visual pathway as a model to understand brain damage in multiple sclerosis
TLDR
The visual pathway represents a model of acute focal central nervous system (CNS) damage, through acute optic neuritis and retinal periphlebitis, as well as a models of chronic, diffuse CNS damage through chronic retinopathy and optic neuropathy. Expand
Multifocal visual evoked potential analysis of inflammatory or demyelinating optic neuritis.
TLDR
The mVEP test is a sensitive and specific tool for detecting optic neuritis andLatency results suggest a role in identifying a patient's risk for future MS. Expand
Optic nerve diffusion changes and atrophy jointly predict visual dysfunction after optic neuritis
Recently, there has been strong interest in the development of imaging techniques to quantify axonal and myelin pathology in patients with multiple sclerosis (MS). Optic neuritis, a conditionExpand
Optic neuritis as a phase 2 paradigm for neuroprotection therapies of multiple sclerosis: update on current trials and perspectives.
TLDR
Optic neuritis as a prototypic autoimmune demyelinating disease offers an option for testing new therapies targeting key deleterious processes in multiple sclerosis and the window of opportunity for therapeutic interventions is opened. Expand
Evaluation of pattern-reversal visual evoked potential in patients with neuromyelitis optica
TLDR
Evaluation of VEP in patients with definite NMO revealed a pattern that is different from that of MS in 81.6% of eyes examined, characterized by the absence of responses, or decreased amplitude with normal latency. Expand
The Afferent Visual Pathway: Designing a Structural-Functional Paradigm of Multiple Sclerosis
TLDR
The parameters and merits of the AVP model, a functionally eloquent system that is amenable to interrogation with highly reliable and reproducible tests that can be used to define a structural-functional paradigm of CNS injury, are highlighted. Expand
Latency of multifocal visual evoked potentials in nonoptic neuritis eyes of multiple sclerosis patients associated with optic radiation lesions.
TLDR
The hypothesis that latency delay of the mfVEP in eyes of MS patients without previous ON is related to retrogenicular demyelinating lesions is supported and a previous episode of ON in the fellow eye may be a significant confounding factor, masking the relationship between the latency and OR lesions. Expand
Fellow eye changes in optic neuritis correlate with the risk of multiple sclerosis
TLDR
The magnitude of latency prolongation and amplitude decline 12 months after the initial episode of unilateral optic neuritis was proportional to the risk of MS. Expand
MRI of optic nerve and postchiasmal visual pathways and visual evoked potentials in secondary progressive multiple sclerosis
TLDR
Optic nerve total lesion length and area on the STIR sequence was found to correlate significantly with prolongation of the VEP latency, which may reflect a predominantly demyelinating rather than inflammatory origin for the signal change in the optic nerve. Expand
Axonal loss in non–optic neuritis eyes of patients with multiple sclerosis linked to delayed visual evoked potential
TLDR
There was significant association between RNFL loss and a latency delay of the mfVEP in MS-NON eyes, and in patients with no previous optic neuritis in either eye, delayed latency and reduced RNFL were bilateral whenever present. Expand
...
1
2
3
4
5
...